Maija Itälä-Remes profile picture
Maija
Itälä-Remes
Professor, Internal Medicine
MD, PhD, Adjunct professor

Areas of expertise

Haematology
Acute Leukemia
Haematopoietic Stem Cell Transplantation

Biography

Academic degrees:

Medical doctor 26.5.1986, University of Turku, Finland
Doctoral thesis (”B-cell Chronic Lymphocytic Leukemia and Increased Susceptibility to Infections”) and 13.9.1996, University of Turku
Doctorate, PhD 4.12.1997, University of Turku
Adjunct professor Internal Medicine/Clinical Haematology 18.4.2005, University of Turku

Professional appointments:

Resident/specialist in Internal Medicine and in Anaesthesia 1986-1997 Turku University Central Hospital.
Clinical haematologist, Turku University Central Hospital 1997-2007.
Medical Adviser, Janssen-Cilag, Nordic Section 2007-2008.  
Head of Department of Haematology, Tampere University Central Hospital 2008-2010.
Head of Stem Cell Transplant Unit, Turku University Hospital 2010-2017.
Head of Stem Cell Transplant Unit, Helsinki University Hospital 2017-2018.
Head of Division of Clinical Haematology and Stem Cell Transplant Unit, Programme Director of Stem Cell Transplant Unit, Turku University Central Hospital 2018-

Dissertations:

Supervisor 3, Opponent 2, Reviewer 4

Other academic appontments:

Review of the scientific work for docent application

Appointments in Scientific Societies:

Chair of the Finnish Society of Haematology 2012-2014, member 2014-.
Chair of the Finnish Acute Leukemia Working Group 2015-2018, member 2018-
The Nordic-Dutch Working Group for CLL (Chronic Lymphocytic Leukemia) Group, member 2000-2014.
The Finnish Haematology Registry and Biobank, member of the Steering group 2012-2014.
The European Group for Blood and Marrow Transplantation, member 1997-

Duties with National Authorities:

Consultant of the Parliament (Implementation of EU directives into National legislation) 2006-2007
Consultant of the Ministry of Social Affairs and Health (STM) 2016
Consultant of the Finnish Medicine Agency (Fimea) 2016-2018
EU consultation Brussels 2017

Activities in Quality Management:

Inspector exam of FACT/JACIE Quality Management System 31.5.2011, Rotterdam.
Establishment of the Quality Management System of the Stem Cell Unit of Turku University Hospital 2006; Moderation of initial JACIE accreditation and two re-accreditations 2006-2017 Turku University Central Hospital, Turku.


Teaching

Lectures at Finnish University Hospitals and Central Hospitals

Public lectures

Lectures at International meetings

Education of residents and junior colleagues (Clinical haematology and Stem Cell Transplantations)

Member of Faculty of the International Congress on Stem Cell Transplantation and Cellular Therapies, Berlin 2017

Research

Scientific publications and text book articles in field of stem cell transplantions and haematological malignancies

Principal Investigator and Sub-investigator of International Multicentre Clinical Trials

GCP training, latest update 22.2.2018

Publications

Sort by:

Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT (2023)

Haematologica
Devillier Raynier, Eikema Dirk-Jan, Dufour Carlo, Aljurf Mahmoud, Wu Depei, Maschan Alexei, Kulagin Alexander, Halkes Constantijn J. M., Collin Matthew, Snowden John, Renard Cecile, Ganser Arnold, Sykora Karl-Walter, Gibson Brenda E., Maertens Johan, Itala-Remes Maija, Corti Paola, Cornelissen Jan, Bornhaeuser Martin, Colorado Araujo Mercedes, Ozdogu Hakan, Risitano Antonio, Socie Gerard, de latour Regis Peffault
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of the EBMT (2023)

HemaSphere
Kharfan-Dabaja MA, Labopin M, Ayala E, Bazarbachi A, Blaise D, Vydra J, Bramanti S, Itala-Remes M, Schmid C, Busca A, Forcade E, Rabitsch W, Zecca M, Kroger N, Bulabois CE, Grillo G, Rambaldi A, Fanin R, Zallio F, Di Renzo N, Koc Y, Novis Y, McDonald A, Arroyo CH, Sanz J, Nagler A, Ciceri F, Mohty M
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Efficacy of conventional-dose cytarabine, idarubicin and thioguanine versus intermediate-dose cytarabine and idarubicin in the induction treatment of acute myeloid leukemia: Long-term results of the prospective randomized nationwide AML-2003 study by the Finnish Leukemia Group (2022)

European Journal of Haematology
Kolonen Aarne, Sinisalo Marjatta, Huhtala Heini, Rimpiläinen Johanna, Rintala Hannele, Sankelo Marja, Koivunen Elli, Silvennoinen Raija, Räty Riikka, Ruutu Tapani, Volin Liisa, Porkka Kimmo, Jantunen Esa, Nousiainen Tapio, Kuittinen Taru, Penttilä Karri, Pyörälä Marja, Säily Marjaana, Koistinen Pirjo, Kauppila Marjut, Itälä-Remes Maija, Ollikainen Hanna, Rauhala Auvo, Kairisto Veli, Pelliniemi Tarja-Terttu, Elonen Erkki; Finnish Leukemia Group
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia (2022)

Haematologica
Kuusanmäki Heikki, Kytölä Sari, Vänttinen Ida, Ruokoranta Tanja, Ranta Amanda, Huuhtanen Jani, Suvela Minna, Parsons Alun, Holopainen Annasofia, Partanen Anu, Kuusisto Milla EL, Koskela Sirpa, Räty Riikka, Itälä-Remes Maija, Västrik Imre, Dufva Olli, Siitonen Sanna, Porkka Kimmo, Wennerberg Krister, Heckman Caroline A, Ettala Pia, Pyörälä Marja, Rimpiläinen Johanna, Siitonen Timo, Kontro Mika
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Seasonal human coronaviruses respiratory tract infection in recipients of allogeneic hematopoietic stem cell transplantation (2021)

Journal of Infectious Diseases
Piñana JL, Xhaard A, Tridello G, Passweg J, Kozijn A, Polverelli N, Heras I, Perez A, Sanz J, Berghuis D, Vázquez L, Suárez-Lledó M, Itäla-Remes M, Ozcelik T, Iturrate Basarán I, Al Zahrani M, Karakukcu M, Cuesta Casas MA, Choi G, Viviana A, Batlle Massana M, Ganser A, Blijlevens N, Labussière-Wallet H, Kuskonmaz B, Arzu Yegin Z, Shaw PJ, Rocha V, González-Vicent M, Knelange N, Ferster A, de la Camara R, Styczynski J, Navarro D, Mikulska M, Styczynski J; Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation and Infectious Complications Subcommittee of the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group
(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))